AnaptysBio Inc buy Guggenheim
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€34.37
Performance (%)
159.72%
End price
13.12.25
€37.40
Summary
This prediction ended on 13.12.25 with a price of €37.40. With a performance of 159.72% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 9.474% | 9.474% | 201.449% |
| iShares Core DAX® | 0.299% | 4.557% | 21.480% |
| iShares Nasdaq 100 | 0.666% | 2.752% | 6.184% |
| iShares Nikkei 225® | -0.656% | 0.000% | 13.889% |
| iShares S&P 500 | 0.352% | 1.854% | 3.566% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Guggenheim from $90.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten